Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.,
Cardenas, Mariano G., Yu Wenbo, Béguelin Wendy, Teater Matthew R., Geng Huimin, Goldstein Rebecca L., Oswald Erin, Hatzi Katerina, Yang Shao-Ning, Cohen Joanna, et al.
, J Clin Invest, 2016 Sep 01, Volume 126, Issue 9, p.3351-62, (2016)